![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0911.jpg)
What about the GCB Phenotype?...anything yet in the front line?
McCabe M T et al
. Proc Nat Acad Sci USA
2012;109:2989-2994
►
Enhancer of Zeste 2 (EZH2) is the enzyme
component of the Polycomb Repressive
Complex 2 (PRC2) that methylates histone
H3 on lysine 27 (H3K27)
►
Somatic activating mutations in EZH2 have
been identified in follicular and GCB-DLBCL
[Morin, 2010; Morin, 2011; Pasqualucci,
2011];
►
The frequency of the most prevalent
mutation, Y641, 22% in DLBCL.
►
Inhibitors in early phase investigation